NHS England commissioned NHS Commissioning Support Units as a collaborative to develop and complete a survey of a sample of NHS Trusts to identify the barriers to update of biosimilars, with a focus on CCG commissioned biosimilars.
The documents on this page describe the process followed and present the results on this work. They include:
- A pre-survey pilot questionnaire undertaken in the North region
- Results from a national survey of CCGs
- Results from a national survey of NHS Trusts
- An executive summary of the work in totality
Assistant Head (Medicines Optimisation), Specialist Pharmacy Service